rs117537178

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_004204.5(PIGQ):​c.1568G>A​(p.Gly523Asp) variant causes a missense change. The variant allele was found at a frequency of 0.00184 in 1,603,782 control chromosomes in the GnomAD database, including 50 homozygotes. In-silico tool predicts a benign outcome for this variant. 10/17 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G523S) has been classified as Benign.

Frequency

Genomes: 𝑓 0.0031 ( 13 hom., cov: 33)
Exomes 𝑓: 0.0017 ( 37 hom. )

Consequence

PIGQ
NM_004204.5 missense

Scores

5
11

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 5.02

Publications

1 publications found
Variant links:
Genes affected
PIGQ (HGNC:14135): (phosphatidylinositol glycan anchor biosynthesis class Q) This gene is involved in the first step in glycosylphosphatidylinositol (GPI)-anchor biosynthesis. The GPI-anchor is a glycolipid found on many blood cells and serves to anchor proteins to the cell surface. This gene encodes a N-acetylglucosaminyl transferase component that is part of the complex that catalyzes transfer of N-acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI). Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2012]
PIGQ Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 77
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0068854094).
BP6
Variant 16-582284-G-A is Benign according to our data. Variant chr16-582284-G-A is described in ClinVar as Benign. ClinVar VariationId is 456036.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population amr. GnomAd4 allele frequency = 0.00312 (476/152350) while in subpopulation AMR AF = 0.0223 (341/15310). AF 95% confidence interval is 0.0203. There are 13 homozygotes in GnomAd4. There are 274 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 13 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PIGQNM_004204.5 linkc.1568G>A p.Gly523Asp missense_variant Exon 10 of 11 ENST00000321878.10 NP_004195.2
PIGQNM_148920.4 linkc.1532-599G>A intron_variant Intron 9 of 9 NP_683721.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PIGQENST00000321878.10 linkc.1568G>A p.Gly523Asp missense_variant Exon 10 of 11 1 NM_004204.5 ENSP00000326674.6

Frequencies

GnomAD3 genomes
AF:
0.00310
AC:
472
AN:
152232
Hom.:
13
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000289
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0220
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00520
Gnomad SAS
AF:
0.0165
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000118
Gnomad OTH
AF:
0.00430
GnomAD2 exomes
AF:
0.00576
AC:
1381
AN:
239624
AF XY:
0.00570
show subpopulations
Gnomad AFR exome
AF:
0.000390
Gnomad AMR exome
AF:
0.0236
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00471
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000466
Gnomad OTH exome
AF:
0.00461
GnomAD4 exome
AF:
0.00171
AC:
2480
AN:
1451432
Hom.:
37
Cov.:
31
AF XY:
0.00201
AC XY:
1446
AN XY:
720636
show subpopulations
African (AFR)
AF:
0.000240
AC:
8
AN:
33298
American (AMR)
AF:
0.0223
AC:
989
AN:
44310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25996
East Asian (EAS)
AF:
0.00277
AC:
109
AN:
39348
South Asian (SAS)
AF:
0.0144
AC:
1231
AN:
85412
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
51026
Middle Eastern (MID)
AF:
0.000174
AC:
1
AN:
5754
European-Non Finnish (NFE)
AF:
0.0000163
AC:
18
AN:
1106414
Other (OTH)
AF:
0.00207
AC:
124
AN:
59874
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.443
Heterozygous variant carriers
0
84
168
251
335
419
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00312
AC:
476
AN:
152350
Hom.:
13
Cov.:
33
AF XY:
0.00368
AC XY:
274
AN XY:
74502
show subpopulations
African (AFR)
AF:
0.000289
AC:
12
AN:
41584
American (AMR)
AF:
0.0223
AC:
341
AN:
15310
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00521
AC:
27
AN:
5178
South Asian (SAS)
AF:
0.0163
AC:
79
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10630
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.000118
AC:
8
AN:
68024
Other (OTH)
AF:
0.00425
AC:
9
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
22
43
65
86
108
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000433
Hom.:
0
Bravo
AF:
0.00413
ESP6500AA
AF:
0.000228
AC:
1
ESP6500EA
AF:
0.000116
AC:
1
ExAC
AF:
0.00521
AC:
629
Asia WGS
AF:
0.0120
AC:
43
AN:
3478
EpiCase
AF:
0.0000545
EpiControl
AF:
0.000178

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

PIGQ-related disorder Benign:1
Apr 17, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Epilepsy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.091
BayesDel_addAF
Benign
-0.32
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
21
DANN
Uncertain
1.0
DEOGEN2
Benign
0.021
.;.;T
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.24
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.64
.;T;T
MetaRNN
Benign
0.0069
T;T;T
MetaSVM
Benign
-0.93
T
PhyloP100
5.0
PROVEAN
Benign
-0.99
N;N;N
REVEL
Benign
0.24
Sift
Benign
0.42
T;T;T
Sift4G
Uncertain
0.050
T;T;T
Polyphen
1.0
D;D;.
Vest4
0.40
MVP
0.55
ClinPred
0.037
T
GERP RS
3.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.0
Mutation Taster
=92/8
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117537178; hg19: chr16-632284; COSMIC: COSV50320204; COSMIC: COSV50320204; API